Target antigens for CAR T cells in prostate cancer include prostate-specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), KLK2, and six-membrane epithelial antigen of the prostate-1 (STEAP-1), mainly as monotherapies and with limited success thus far5–9. This evidence concerns the gene PSCA and prostate carcinoma.